Based on RNA-seq data from The Cancer Genome Atlas and several Gene Expression Omnibus datasets, a 14-gene hypoxia-related signature, which included VHL, was developed and the findings revealed that this signature could serve as a potential prognostic biomarker for breast cancer [88]. Here, VHL is linked to breast cancer.